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Background/aim: Pulmonary microvascular endothelial cells (PMVECs) play a pivotal role in the process of acute lung injury (ALI),
which can be induced by lipopolysaccharide (LPS). Numerous reports have indicated that both miR-33 and RIP140 are involved in the
inflammatory response in macrophages. In this study, we sought to investigate whether miR-33 and RIP140 participate in ALI induced
by LPS.
Materials and methods: First, we isolated and identified PMVECs from BALB/c mice. Subsequently, both PMVECs and BALB/c mice
were treated with PBS, LPS, or pyrrolidine dithiocarbamate (PDTC) plus LPS and divided into three groups: control (PBS), LPS (LPS),
and L+P (LPS plus PDTC) groups. We assessed pathology by hematoxylin and eosin staining, and miR-33 and RIP140 expression levels
were examined using quantitative PCR and Western blot analyses.
Results: Our results demonstrated that LPS can induce PMVEC injury and ALI and that LPS treatment significantly decreased miR-33
expression compared with controls (P < 0.001, n = 5). On the contrary, RIP140 was markedly overexpressed by LPS treatment (P < 0.001,
n = 5). However, this alteration can be inhibited by pretreatment with PDTC before LPS (P < 0.05, n = 5).
Conclusion: This study is the first to confirm that both miR-33 and RIP140 participate in LPS-induced PMVEC injury and ALI, which
may help uncover the mechanism of ALI.
Key words: Lipopolysaccharide, PMVEC, acute lung injury, miR-33 and RIP140

1. Introduction
Acute lung injury (ALI) is a critical clinical disease caused
by uncontrolled inflammation (1). Mortality due to ALI is
high at 35%–40%, but its detailed pathogenic mechanism
remains unclear. Overexpression of inflammatory
mediators as a result of a variety of factors excluding
cardiogenic factors can lead to ALI, and sepsis represents
one of the major factors (2). Lipopolysaccharide (LPS) is the
main component of the outer membrane of gram-negative
bacteria, which are a major pathogenic cause of sepsis
(3). In sepsis, LPS can attack pulmonary microvascular
endothelial cells (PMVECs), resulting in leakage of
protein-rich edema fluid as a result of PMVEC injury
and barrier dysfunction. Moreover, the main pathologic
feature of ALI is pulmonary edema due to the increase in
PMVEC permeability (4,5). Therefore, PMVEC function
is receiving increasing attention in ALI research.
MicroRNA-33 (miR-33) is an intronic miRNA that
encodes sterol-regulatory element-binding factor-2,
which is involved in atherosclerosis, as it is the target of

ATP-binding cassette transporter A1 (ABCA1) and ATPbinding cassette transporter G1 (ABCG1) (6,7). However,
a recent study suggested that miR-33 also participates
in inflammatory reactions. For example, when BALB/c
mice were intraperitoneally injected with LPS to induce
acute inflammation and ALI, miRNA microarray analyses
revealed that LPS-induced inflammation significantly
downregulates miR-33 expression by approximately 0.57fold after 24 h (8). Furthermore, Jin et al. discovered that
LPS and IFN-gamma stimulation can also significantly
downregulate the expression of miR-33 in dendritic cells
by approximately 1.41-fold (9).
Receptor-interacting protein 140 (RIP140) is a
transcriptional coregulator of numerous transcription
factors and a regulator of signal transduction (10–
12). Previous studies have suggested that RIP140 can
negatively regulate energy homeostasis by affecting the
storage of lipids and inhibiting the expression of genes
involved in fatty acid oxidation and glucose metabolism
(13). However, Zschiedrich et al. reported that genetic
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factors and acute deficiency of RIP140 lead to inhibition
of the proinflammatory program in macrophages (14).
When macrophages were treated with modified lowdensity lipoprotein (oX-LDL, an inflammatory stimulus),
IL-1β and TNF-α levels were increased due to NF-κB
coactivation by RIP140 (14). The mechanism involved the
modification of low-density lipoprotein, which leads to the
accumulation of cholesterol and activates the cholesterolmiR-33-RIP140 regulatory pathway that modulates the
proinflammatory potential of macrophages in response
to altered intracellular cholesterol status (10). Moreover,
RIP140 overexpression can increase proinflammatory
gene expression and cytokine release, and these effects
can be reversed by p65-NF-κB inhibition in neonatal rat
cardiomyocytes (15).
Clearly, both miR-33 and RIP140 are associated with
inflammatory reactions. However, Guo et al. demonstrated,
only by miRNA microarray analyses, that miR-33
expression was reduced; further validation by quantitative
PCR analysis was not performed (8). Moreover, RIP140
is mainly expressed in metabolic tissues; thus, it remains
unclear whether lung cells express RIP140 and its role
in ALI. In addition, the possible relationship between
RIP140 and PMVEC injury during inflammation remains
uncharacterized. Therefore, to uncover their possible
roles and relationship with miR-33 and RIP140 in LPSinduced ALI, both primary PMVECs and BALB/c mice
were treated with phosphate-buffered saline (PBS), LPS,
or LPS plus pyrrolidine dithiocarbamate (PDTC), which
is a specific inhibitor of NF-κB (16,17). Subsequently, we
assessed their pathology and detected miR-33 and RIP140
expression.
2. Materials and methods
2.1. Isolation and culture of mouse PMVECs
PMVECs were isolated from mouse lung tissue as previously
reported (18). Briefly, three 6- to 8-day-old BALB/c mice
were anesthetized. Then, strips of peripheral lung were
removed, and the tissue was finely minced using sterile
scissors. The tissue was incubated in 1% gelatin-coated
25-cm2 tissue culture flasks in growth media. All tissue
was removed after 65 h. After subculture, PMVECs were
seeded on slides and identified by immunofluorescence
staining for factor VIII (BIOSS Biological technology,
Inc., Beijing, China) expression. Slides were analyzed by
inverted fluorescence microscopy.
2.2. Cell model of PMVEC injury
PMVECs were seeded in 6-well plates. Before treatment
with 100 ng/mL LPS (Sigma‑Aldrich; Merck KGaA,
Darmstadt, Germany), the L+P (LPS plus PDTC) group
was treated with 100 μmol/L PDTC (Beyotime Institute of
Biotechnology, Haimen, China). After 1 h, the LPS and L+P
groups were exposed to LPS (100 ng/mL), while the control

(PBS) group was treated only with PBS. Twelve hours later,
the culture supernatant and cells were collected. The main
pathologic feature of ALI is pulmonary edema due to
increased PMVEC permeability. Moreover, when PMVECs
were treated with LPS, their permeability changed, and
LDH was released from PMVECs. Therefore, LDH is
considered a major index of permeability levels (19), and
LDH was measured using a Lactate dehydrogenase assay
kit (Jiancheng Bioengineering Institute, Nanjing, China)
in this study. The expression levels of miR-33 and RIP140
in cells were also measured.
2.3. Animal model of ALI
Fifteen BALB/c mice weighing 26 ± 3 g (5 to 6 weeks old)
were obtained from the Experimental Animal Center of
Nanchang University (Nanchang, China). All mice were
maintained under a 12-h light/dark cycle and supplied
with standard food and water. Sepsis was induced in mice
as previously described (20,21). Briefly, the mice were
divided into three groups (5 per group): control, LPS,
and L+P (LPS + PDTC) groups. First, the L+P group was
intraperitoneally injected with 30 mg/kg PDTC (PDTC was
dissolved in 50 μL of PBS). Simultaneously, both the control
and LPS groups were intraperitoneally injected with the
same volume of PBS (50 μL). One hour later, mice in the
LPS and L + P groups were intraperitoneally injected with
10 mg/kg LPS (LPS was dissolved in 50 μL of PBS), which
was purchased from Solarbio (Beijing Solarbio Science &
Technology Co., Ltd., Beijing, China). However, the mice
in the control group were intraperitoneally injected with
only 50 μL of PBS. Mouse survival was monitored every
hour for 24 h. The mice were then euthanized by cervical
dislocation, and the lungs were collected for analysis. This
study obtained ethical approval from the Committee on
Animal Experimentation of Nanchang University, and the
procedures complied with the NIH Guide for the Care and
Use of Laboratory Animals.
2.4. Hematoxylin and eosin staining
To ensure successful construction of the animal model of
ALI, mouse lungs were fixed in 10% formaldehyde. The
fixed tissues were then embedded in paraffin and cut
into 4-μm sections using a microtome (Leica, Nussloch,
Germany). The sections were placed on glass slides,
deparaffinized, and stained with hematoxylin and eosin
(21,22). These results were viewed using an inverted
fluorescence microscope (IX-71 OLYMPUS).
2.5. Quantitative PCR analysis
RNA was isolated using RNAiso Plus reagent (Takara
Biotechnology Co., Ltd., Dalian, China) according to the
manufacturer’s protocol. Total RNA (0.5 μg) was used for
reverse transcription in a total volume of 5 μL (Thermo
Fisher Scientific, Inc., Waltham, MA, USA). RIP140,
miR-33, β-actin, and U6 primers were synthesized
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by Invitrogen. The primer sequences were as follows:
RIP140 forward GGCAGCAAACCTGAATTCGGC,
reverse
CTCACCGGGCACGGAACATC;
β-actin
forward
TGAGCTGCGTTTTACACCCT,
reverse
GCCTTCACCGTTCCAGTTTT;
miR-33
forward
A C A C T C C A G C T G G G G T G C A T T G T A G T T,
reverse CTCAACTGGTGTCGTGGAGT; and U6
forward
GTGCTCGCTTCGGCAGCA,
reverse
CAAAATATGGAACGCTTC.
To measure the expression of these genes, SYBR Green
was used as a fluorescent dye (Thermo Fisher Scientific,
Inc.). The PCR program (ABI 7500 sequence detection
system) comprised of 95 °C for 3 min and 40 cycles of 95
°C for 10 s and 60 °C for 1 min. Fluorescence data and
melting curves were obtained. Experimental data represent
the average and standard deviation of three biological
replicates. RIP140 expression was normalized to β-actin
expression, and miR-33 expression was normalized to U6
snRNA expression (23).
2.6. Western blot analysis
Proteins were extracted using radioimmunoprecipitation
buffer (Kangwei Century Biotechnology Co., Ltd.),
and protein concentrations were measured using a
bicinchoninic acid (BCA) assay (Kangwei Century
Biotechnology Co., Ltd., Beijing, China). Equal amounts
of clear lysates were separated by sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE) and then
transferred onto polyvinylidene fluoride membranes
(Immobilon P, Millipore, Bedford, MA, USA). Equal
transfer was validated by staining with Ponceau red. The
membranes were blocked with 10% skim milk in Trisbuffered saline (TBS) and then incubated with primary
antibodies in TBS containing 0.05% Tween 20, 2% bovine
serum albumin, and 0.05% sodium azide overnight at 4
°C. The following antibodies were used at the indicated
dilutions: RIP140 (Santa Cruz Biotechnology, Inc., Dallas,
TX, USA) at 1:1,000 and β-actin at 1:10,000 (ProteinTech
Group, Inc., Wuhan, China). Secondary horseradish
peroxidase-conjugated antibodies (rabbit, ProteinTech
Group, Inc., Wuhan, China) were used at 1:10,000 in 10%
skim milk in TBS containing 0.05% Tween 20 (24). Signals
were revealed using an enhanced chemiluminescence
reagent (Kangwei Century Biotechnology Co., Ltd.) and
an autoradiography system (CLINX, Chemiluminescence
Imaging System).
2.7. Statistical analysis
Statistical analyses were performed using the statistical
software SPSS22.0, and significant differences between
groups were evaluated using Student’s paired t-test. For
multiple comparisons, one-way ANOVA with Tukey’s or
Games–Howell post hoc analysis was used. All experiments
were repeated at least 3 times, and P < 0.05 was considered
statistically significant.
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3. Results
3.1. Identification of PMVECs and the cell injury model
To understand the possible function of PMVECs in ALI,
we isolated PMVECs and constructed a cell injury model.
Immunofluorescence staining results showed that the
cells isolated from the mouse lung were true PMVECs, as
shown by positive factor VIII expression (Figure 1). When
cells were treated with 100 ng/mL LPS, the LDH levels in
the culture supernatant were increased by approximately
3.16 ± 0.45-fold in the LPS group compared with those in
the control group (Figure 2A, P < 0.001, n = 3). Compared
with LPS, PDTC (L+P) significantly inhibited this change
(P < 0.05, n = 3). However, the levels of LDH were
increased by approximately 1.85 ± 0.36-fold (P < 0.001, n
= 3) compared with those in the control group.
3.2. Identification of the ALI mouse model
Inflammation alters miR-33 and RIP140 expressions in
PMVECs. Furthermore, we assessed miR-33 and RIP140
expression in the lungs of the ALI model mice. Therefore,
we first constructed the ALI mouse model using LPS. To
assess the pathological changes, HE staining was used in
our study. As noted in Figure 2B, lung tissues from the
control group exhibited normal structures. In contrast,
exudate and blood were noted in the alveoli of the model
(LPS) group, and alveolar wall capillaries were dilated
and congested. In addition, dense lymphocyte infiltration
was noted on the capillary wall (Figure 2B). However,
the degree of injury in the L+P group was more severe
than that in the control group and was less severe than
that in the LPS group. In addition, exudate and blood in
mouse lung tissue were not notable in the PDTC group,
and minimal inflammatory cell infiltration was noted
(Figure 2B). Hence, the mouse ALI model was successfully
generated.
3.3. Expression of miR-33 in PMVECs and mouse lungs
miR-33 is involved in atherosclerosis, which is a chronic
inflammatory process. Thus, we measured miR-33
expression in injured PMVECs and mouse lung tissue
induced by LPS. As demonstrated in Figure 3A, miR-33
expression was reduced by approximately 0.55 ± 0.06fold in PMVECs (P < 0.001, n = 3). Moreover, Figure 3B
shows that miR-33 expression was downregulated in the
mouse lung after exposure to LPS. miR-33 expression
levels were decreased by approximately 0.44 ± 0.11-fold
compared with those in the control group (P < 0.001, n
= 5). However, PDTC reversed this alteration (Figure 3)
in PMVECs and mouse lungs. Compared with the control
group, the L+P group showed an approximate reduction
in miR-33 expression of 0.31 ± 0.02- and 0.20 ± 0.03-fold
in PMVECs and mouse lungs (P < 0.05 or 0.001, n = 3
or 5), respectively, and these reductions were statistically
significant compared with miR-33 expression in the LPS
group (P < 0.05 or 0.001, n = 3 or 5).
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Figure 1. Identification of PMVECs. (A)-Inverted microscopy revealing PMVEC morphology. (B)-Identification of PMVECs by
immunofluorescence staining for factor VIII expression.

Figure 2. Evaluation of LPS-induced PMVECs and mouse lung injury. (A)-LDH levels in the PMVEC culture supernatant (μmol/g) are
reported as LDH/protein. Values are presented as the mean ± SD (PMVEC n = 3; mouse n = 5). ** P < 0.001, the LPS group compared
with the control group; # P < 0.05, the L+P group compared with the LPS group. (B)-Representative light micrographs of HE-stained
lung tissues from the control, LPS, and L+P groups after 24 h.
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3.4. RIP140 expression in PMVECs and mouse lungs
Given that RIP140 is the target gene of miR-33 (10), we assessed whether PMVECs and mouse lungs express RIP140
and assessed the effect of inflammation on RIP140 expression in PMVECs and the lungs of ALI mice. First, we mea-

sured RIP140 expression by qPCR and Western blot analysis. Figure 4 reveals that RIP140 is expressed in PMVECs
and mouse lung tissue. RIP140 mRNA and protein levels
were approximately 1.86 ± 0.11- and 1.6 ± 0.17-fold (Figures 4A and 4B, P < 0.001, n = 3) increased, respectively,

Figure 3 Expression of miR-33 in PMVECs and mouse lungs treated with LPS. The
expression of miR-33 in PMVECs (A) and mouse lungs (B). Expression levels were analyzed
by real-time quantitative PCR. Values are shown as the mean±SD (PMVEC n=3; mouse n=5).
*P<0.05 and **P<0.001, the LPS group compared with the control group; #P<0.05, the L+P
group compared with the LPS group.

Figure 4 RIP140 expression in PMVECs and mouse lungs treated with LPS. RIP140 mRNA and protein levels in PMVECs (A and B)
and mouse lungs (C and D) as analyzed by real-time quantitative PCR and Western blot analysis, respectively. Values are presented as
the mean±SD (PMVEC n=3; mouse n=5). **P<0.001, the LPS group compared with the control group; #P<0.05 and ##P<0.001, the L+P
group compared with the LPS group.
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in PMVECs after LPS treatment compared with control
PMVECs. We also added 100 μmol/L PDTC before LPS
treatment, which attenuated PMVEC lesions, decreased
the release of LDH into the culture medium (Figure 2A),
and suppressed the alterations in RIP140 expression induced by LPS (Figures 4A and 4B, P < 0.05 or 0.001, n
= 3). Furthermore, we measured RIP140 expression in
mouse lungs (Figure 4B), which revealed significant overexpression of RIP140 mRNA and protein in the LPS group
compared with the control group (Figures 4C and 4D, P
< 0.001, n = 5). The levels of RIP140 mRNA and protein
were increased by approximately 1.89 ± 0.08- and 2.27 ±
0.15-fold in the LPS group and control group, respectively.
In the L+P group, RIP140 mRNA and protein expression
was increased by only approximately 1.36 ± 0.14- and 1.52
± 0.13-fold (Figures 4C and 4D, P < 0.05, n = 5), respectively. These levels were reduced compared with those in
the LPS group (P < 0.05, n = 5). Based on these results, we
inferred that RIP140 expression was negatively correlated
with miR-33 expression in PMVECs and mouse lungs.
4. Discussion
In this study, we discovered that miR-33 expression was
reduced, whereas the target gene of miR-33, RIP140, was
overexpressed in both LPS-treated PMVECs and BALB/c
mice. However, PDTC relieved these alterations. Clearly,
both miR-33 and RIP140 expression are tightly associated
with inflammation.
Atherosclerosis is a chronic inflammatory process, and
microRNA-33 is involved in atherosclerosis; therefore,
miR-33 is also thought to be associated with inflammation
(6,7,25,26). For example, inhibition of LPS-induced NFκB activation further reduced miR-33 expression and
enhanced ABCA1 expression and cholesterol efflux in
macrophages (25,26). Moreover, transfection of Raw264.7
macrophages with miR-33 suppressed the LPS-stimulated
production of TNF-α and IL-1β mRNA. Consistently, the
levels of secreted TNF-α and IL-1β in cell culture media
were also reduced (11). These studies only show that
miR-33 regulates inflammation in macrophages but not
in other cells and tissues. Moreover, the study by Guo et
al. demonstrated that an inflammatory stimulus (LPS)
can modulate the expression of miR-33 in the lungs
according to miRNA microarray analysis but did not
confirm this finding by other experimental techniques
(8). However, the present results (Figure 3B) confirmed
that the expression of miR-33 was downregulated in the
lungs of ALI model mice. This finding suggested that
miR-33 may be involved in inflammatory reactions of the
lungs. Furthermore, when mice were intraperitoneally
injected with LPS plus PDTC, which can attenuate the
inflammatory response by inhibiting NF-κB (16,17,20),

the changes induced by LPS were reduced compared
with those in mice treated with LPS only. Clearly, these
experimental phenomena further demonstrated that miR33 expression depends on inflammation. In the process of
ALI, PMVECs are the main component of the pulmonary
alveolar-capillary membrane (4,5). Therefore, this study
analyzed the possible function of miR-33 and RIP140
in PMVEC injury. Figure 3A demonstrates that miR-33
expression in injured PMVECs is significantly reduced (P
< 0.001, n = 5) to levels similar to those noted in the lungs
of ALI mice (Figure 3B). Altogether, these results indicate
that miR-33 may play an important role in inflammatory
injury in PMVECs and mouse lungs.
Previous studies have mainly demonstrated that
RIP140 is expressed in metabolic tissues and negatively
regulates energy homeostasis by affecting lipid storage
and inhibiting the expression of genes involved in fatty
acid oxidation and glucose metabolism (10–13). However,
RIP140 in macrophages also acts as an NF-κB coactivator
by recruiting CREB-binding protein (CBP) to modulate the
TLR-induced production of proinflammatory cytokines,
such as TNF-α and IL-1β (14). Therefore, changes in RIP140
expression can also regulate inflammation and affect TNF-α
and IL-1β levels (14). For example, the overexpression or
silencing of RIP140 in Raw264.7 macrophages enhances
or reduces basal and LPS-stimulated TNF-α and IL-1β
levels (27). In this study, we first demonstrated that both
PMVECs and mouse lungs express RIP140 (Figure 4), and
we found that RIP140 expression was increased in injured
PMVECs and in LPS-induced ALI mouse lungs (Figure 4).
However, RIP140 expression was reduced following PDTC
treatment (Figure 4), as NF-κB activity was inhibited by
PDTC (15). Therefore, RIP140 is clearly regulated by the
degree of inflammatory injury in PMVECs and mouse
lungs, and its expression is negatively associated with miR33.
Although this study elucidated the relationship of miR33 or RIP140 with ALI in vivo and in vitro, a major study
limitation must be noted. Namely, this study did not alter
the expression of miR-33 in PMVECs (or mice) to assess
the detailed relationship of miR-33 and RIP140 with ALI.
Altogether, our study demonstrated that 1) the expression
of miR-33 and RIP140 participate in PMVEC injury in
ALI and 2) RIP140 expression is negatively correlated with
miR-33. These findings may help uncover the mechanism
of ALI.
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